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Introduction
Phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) is the 
major phosphoinositide species in mammalian cells and has 
been associated with numerous molecular events critical for 
cellular signaling. PtdIns(4,5)P2 is hydrolyzed by PLC enzymes 
to generate diacylglycerol and inositol 1,4,5-triphosphate, two 
pivotal second messengers (Berridge, 1993), and it is also con-
verted by class I phosphoinositol 3-kinases to PtdIns(3,4,5)P3 
(Toker and Cantley, 1997). PtdIns(4,5)P2 directly interacts with 
several ion channels, transporters (Fuster et al., 2004; Suh and 
Hille, 2005), and actin binding proteins (Hilpela et al., 2004) 
and regulates enzymes such as PLC and PLD (Liscovitch et al., 
1994; Lomasney et al., 1996). Several molecules within the re-
ceptor internalization machinery also contain inositide binding 
domains, but the exact lipid species that regulates them in the 
cell has not been fi  rmly established (Itoh et al., 2001). It is a 
major challenge to understand how a single type of molecule is 
able to regulate so many processes simultaneously and perhaps 
independently within the plasma membrane (PM).
Part of the problem in studying the multiple functions of 
PtdIns(4,5)P2 is that it is diffi  cult to manipulate  phosphoinositide 
levels within the cells. For example, most data on channel 
  regulation rely upon the addition of phospholipids to excised 
patches and the use of inhibitors such as high concentrations of 
wortmannin to inhibit PtdIns(4,5)P2 formation (Suh and Hille, 
2002; Rohacs et al., 2005). Several attempts have been made to 
alter the level of PtdIns(4,5)P2 in intact cells by expressing either 
phosphatidylinositol 4-phosphate 5-kinase or 5-phosphatase 
(5-ptase) enzymes (Ono et al., 2004; Chen et al., 2006). However, 
prolonged changes in PtdIns(4,5)P2 levels initiate several traf-
fi  cking and signaling events that will alter the disposition of the 
cells by the time the effects are analyzed (Brown et al., 2001). 
This makes it diffi  cult to draw fi  rm conclusions regarding  direct 
effect of the lipid on any single process.
To overcome this problem, we developed a strategy to 
promptly regulate membrane PtdIns(4,5)P2 levels by a drug-
inducible membrane targeting of a type IV 5-ptase enzyme 
(Kisseleva et al., 2000; Kong et al., 2000) based on the het-
erodimerization of the FRB (fragment of mammalian target of 
rapamycin [mTOR] that binds FKBP12) and FKBP12 (FK506 
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apamycin (rapa)-induced heterodimerization of the 
FRB domain of the mammalian target of rapa and 
FKBP12 was used to translocate a phosphoinositide 
5-phosphatase (5-ptase) enzyme to the plasma membrane 
(PM) to evoke rapid changes in phosphatidylinositol 4,5-
bisphosphate (PtdIns(4,5)P2) levels. Rapa-induced PM re-
cruitment of a truncated type IV 5-ptase containing only 
the 5-ptase domain fused to FKBP12 rapidly decreased 
PM PtdIns(4,5)P2 as monitored by the PLCδ1PH-GFP fu-
sion construct. This decrease was paralleled by rapid ter-
mination of the ATP-induced Ca
2+ signal and the prompt 
inactivation of menthol-activated transient receptor po-
tential melastatin 8 (TRPM8) channels. Depletion of PM 
PtdIns(4,5)P2 was associated with a complete blockade of 
transferrin uptake and inhibition of epidermal growth fac-
tor internalization. None of these changes were observed 
upon rapa-induced translocation of an mRFP-FKBP12 fu-
sion protein that was used as a control. These data dem-
onstrate that rapid inducible depletion of PM PtdIns(4,5)P2 
is a powerful tool to study the multiple regulatory roles of 
this phospholipid and to study differential sensitivities of 
various processes to PtdIns(4,5)P2 depletion.
Correspondence to Tamas Balla: ballat@mail.nih.gov
Abbreviations used in this paper: [Ca
2+]i; cytoplasmic Ca
2+; HEK, human 
  embryonic kidney; mRFP, monomeric red ﬂ  uorescent protein; mTOR, mamma-
lian target of rapamycin; PM, plasma membrane; PtdIns(4,5)P2, phosphati-
dylinositol 4,5-bisphosphate; 5-ptase, phosphoinositide 5-phosphatase; rapa, 
rapamycin; Tf, transferrin; Tg, thapsigargin; TRPM8, transient receptor potential 
melastatin 8.JCB • VOLUME 175 • NUMBER 3 • 2006  378
binding protein 12; Muthuswamy et al., 1999). In this approach, 
the phosphatase is fused to the FKBP12 protein, and upon ad-
dition of rapamycin (rapa; or an analogue that does not interact 
with endogenous mTOR protein) the enzyme rapidly translo-
cates to the membrane where its binding partner, the FRB do-
main, is targeted. This method has been successfully used to 
manipulate small GTP binding proteins at the PM (Inoue et al., 
2005) and to study the effects of β-arrestin membrane recruit-
ment (Terrillon and Bouvier, 2004). In the present study we 
show the use of this approach to manipulate PM PtdIns(4,5)P2 
levels and demonstrate how these manipulations affect selected 
processes that are regulated by this phosphoinositide species.
Results and discussion
Targeting of type IV 5-ptase alters PM 
PtdIns(4,5)P2 levels
Fig. 1 shows the concept and the constructs used for rapa-
  induced targeting of the type IV 5-ptase to the PM. For membrane 
targeting of the FRB domain of mTOR, the palmitoylation se-
quence of the human GAP43 protein was used (Tanimura et al., 
2004). To follow their localization, the FRB protein was also 
tagged with either CFP or monomeric red fl  uorescent protein 
(mRFP). The 5-ptase (either full-length or only the 5-ptase 
  domain) was mutated (C641A) to eliminate its C-terminal lipid 
modifi  cation and membrane targeting and was fused to FKBP12 
and also tagged with mRFP (Fig. 1). A mutant form of FRB 
(T2098L of mTOR) that can be heterodimerized with FKBP 
with a rapa analogue (AP21967; rapalogue) that does not bind 
to endogenous mTOR has been recommended. However, be-
cause of its easier availability and faster action, we mostly 
used rapa and the wild-type FRB protein in the present studies. 
Nevertheless, the mutant FRB and the rapalogue have also been 
tested and their use is recommended for applications where rapa 
itself could affect the process being investigated.
To monitor the effects of the 5-ptase on PtdIns(4,5)P2 lev-
els in the PM, these constructs were transfected together with 
the PLCδ1PH-GFP construct in COS-7 cells. Expression of either 
5-ptase constructs in the cytosol at a broad range of expression lev-
els caused no apparent change in the localization of the PLCδ1PH-
GFP, probably because the cytosolic phosphatase is ineffi  cient 
to hydrolyze the lipid in the membrane and because cells 
can make adjustments to maintain their PtdIns(4,5)P2 levels. 
Figure 1.  Rapa-induced translocation of the type IV 5-ptase domain to 
the PM. (A) Outline of the constructs used in the present study. The asterisk 
shows the C641A mutation that eliminates membrane localization of the 
5-ptase. (B) Heterodimerization of the PM-targeted FRB fragment of 
mTOR with the cytosolic 5-ptase fused to FKBP12 upon rapa addition 
causes PM recruitment of the enzyme and rapid dephosphorylation of 
PtdIns(4,5)P2.
Figure 2.  Changes in PtdIns(4,5)P2 levels after rapa-induced membrane 
targeting of the 5-ptase. (A) COS-7 cells were transfected with the PLCδ1PH-
GFP plasmid to monitor PtdIns(4,5)P2 in the PM along with the membrane-
targeted FRB-CFP (CFP channel is not shown) and the mRFP−FKBP−5-ptase 
domain constructs. Addition of 100 nM rapa induces translocation of the 
5-ptase to the membrane, causing a complete loss of PLCδ1PH-GFP local-
ization. Even partial localization of the enzyme (at 30 s) is sufﬁ  cient to 
eliminate PtdIns(4,5)P2. (B) FRET analysis of the PLCδ1PH domain translo-
cation in cell suspensions. COS-7 cells were transfected with the CFP- and 
YFP-tagged forms of the PLCδ1PH domains together with the membrane-
targeted FRB and the FKBP−5-ptase both tagged with mRFP. Cells were 
trypsinized and analyzed in suspension in a spectroﬂ  uorometer as described 
in Materials and methods. Addition of rapa at the indicated concentrations 
induces PtdIns(4,5)P2 depletion resulting in a decreased membrane local-
ization of the PH domain reﬂ  ected in the decreased FRET signal. 10 μM 
ionomycin (iono) was used to completely eliminate PtdIns(4,5)P2 (Várnai 
and Balla, 1998). (C) Similar experiment as in B except that the FKBP 
  construct did not contain the phosphatase (FKBP only; black trace) or 
  contained the full-length 5-ptase (5-ptase−FL; red trace). Representative 
data are shown from two identical observations.INDUCIBLE CHANGES IN MEMBRANE PHOSPHOINOSITIDES • VARNAI ET AL. 379
However, a small number of cells expressing high levels of the 
truncated 5-ptase domain showed no PLCδ1PH-GFP localiza-
tion, indicating that high concentrations of the truncated en-
zyme could decrease lipid levels even without membrane 
  targeting. 100 nM rapa caused rapid translocation of the fusion 
protein containing the 5-ptase domain to the PM causing a 
prompt and complete loss of PLCδ1PH-GFP localization in 
most cells (Fig. 2 A). Using the full-length phosphatase, how-
ever, caused only incomplete translocation of the PLCδ1PH-
GFP reporter to the cytosol in some of the cells, and many cells 
showed no detectable change in PLCδ1PH-GFP localization in 
spite of effi  cient enzyme recruitment to the membrane (unpub-
lished data). This important fi  nding is consistent with the no-
tion that a full-length enzyme contains regulatory regions that 
keep the enzyme activity under control. No changes were ob-
served in PLCδ1PH-GFP distribution upon rapa-induced trans-
location of the mRFP-FKBP fusion protein that did not contain 
the 5-ptase. FRET measurements between the CFP- and YFP-
tagged PLCδ1PH domain (van Der Wal et al., 2001) used either 
in single cells (not shown) or in a population of COS-7 cells 
(Fig. 2 B) have clearly demonstrated the lipid changes evoked 
by this approach.
Decreasing PM PtdIns(4,5)P2 levels 
rapidly terminates Ca
2+ inﬂ  ux during 
ATP stimulation
Next, we examined the effects of PtdIns(4,5)P2 depletion on 
Ca
2+ signaling evoked via the endogenous P2Y receptors in 
COS-7 cells. Cells were transfected with the PM-targeted FRB-
CFP (or -mRFP) together with either the full-length or truncated 
5-ptase mRFP-FKBP fusion construct for 1 d. The expression 
as well as the movements of the 5-ptase were monitored in the 
red channel simultaneously with single-cell cytoplasmic Ca
2+ 
([Ca
2+]i) measurements with fura-2. Addition of 50 μM ATP 
evoked a Ca
2+ signal in many cells expressing the 5-ptase in 
the cytosol, but several cells expressing a high level of the phos-
phatase showed impaired response to ATP. Fig. 3 shows averaged 
Ca
2+ recordings from single cells where the truncated 5-ptase 
domain was expressed and the cells showed a response to ATP. 
Here, administration of rapa promptly terminated the plateau 
phase of [Ca
2+]i increase with kinetics similar to those of the 
PtdIns(4,5)P2 decrease. Notably, these cells failed to respond to 
a subsequent stimulation with another Ca
2+-mobilizing agonist, 
lysophosphatidic acid.
Translocation of the full-length 5-ptase with 100 nM rapa 
also caused a rapid inhibition of the ATP-induced Ca
2+ signal. 
However, these cells still showed a transient [Ca
2+]i response to 
lysophosphatidic acid, indicating that maintenance of the Ca
2+ 
signal is more sensitive to small depletion of the PtdIns(4,5)P2 
levels than the initial response of Ca
2+ mobilization (Fig. 3 C). 
Because activation of P2Y receptors leads to InsP3 production 
and Ca
2+ release form ER stores, hence activating capacitative 
Ca
2+ infl  ux, we wanted to determine whether capacitative Ca
2+ 
infl  ux itself requires PtdIns(4,5)P2 in the membrane (Broad 
et al., 2001). To do this, the effect of lipid depletion on thapsi-
gargin (Tg)-induced Ca
2+ response was examined. Tg depletes 
Ca
2+ stores by inhibition of the sarcoplasmic and ER Ca
2+ 
ATPase that keeps Ca
2+ stores fi  lled and therefore activates 
Ca
2+ infl  ux without the need for InsP3. Fig. 3 D shows that the 
sustained [Ca
2+]i increase after Tg treatment was not affected 
by the same manipulations of PtdIns(4,5)P2 levels that elimi-
nated the ATP-induced sustained Ca
2+ elevations. This fi  nding 
suggests that PtdIns(4,5)P2 depletion interferes with the sus-
tained generation of InsP3 rather than with the capacitative Ca
2+ 
infl  ux mechanism itself. A more detailed analysis of the rela-
tionship between these mechanisms is currently under way.
Several controls were used to rule out that the observed 
effects are caused by rapa itself or by the transfected constructs 
and/or their translocation to the membrane. First, the response 
of cells in the same fi  eld of view not expressing the phosphatase 
were monitored and found to show no change in response to 
rapa. Second, the Ca
2+ response of cells expressing both the tar-
geting construct and mRFP-FKBP12 without the 5-ptase also 
showed no change in response to rapa addition (Fig. 3 B).
Decreasing PM PtdIns(4,5)P2 levels affects 
the activity of transient receptor potential 
melastatin 8 (TRPM8) channels
TRPM8 is one of the Ca
2+ conductive channels that has been 
shown to require PtdIns(4,5)P2 for its activity (Liu and Qin, 
2005; Rohacs et al., 2005). Therefore, we chose these channels 
to study their PtdIns(4,5)P2 dependence by monitoring either 
Figure 3. [Ca
2+]i changes in single COS-7 cells after stimulation of the 
endogenous P2Y receptors with ATP or inhibition of the sarcoplasmic and 
ER Ca
2+ ATPase with Tg. Cells were transfected with the membrane-
  targeted FRB-CFP plasmid together with the mRFP-FKBP fused to the isolated 
5-ptase domain (A and D) or the full-length 5-ptase (C) or not containing 
the 5-ptase (B). Cells were loaded with fura-2/AM and examined at room 
temperature. Only cells that showed a response to ATP (50 μM) were in-
cluded in the analysis in A−C. The effects of the constructs on the Ca
2+ re-
sponses were calculated from cells that fell in the same range of FKBP 
construct expression (red traces) with a mean ﬂ  uorescence of (in arbitrary 
units ± SEM) 1705 ± 150 (n = 44), 1827 ± 295 (n = 18), 1827 ± 217 
(n = 22), and 2117 ± 276 (n = 44) for A, B, C, and D, respectively. The 
black traces are from untransfected cells in the same ﬁ  eld (n = 120, 68, 
120, and 38 for A, B, C, and D, respectively). Note the lack of effect of 
rapa on the 200 nM Tg-induced Ca
2+ elevation (D) in contrast to the 
strong effect on the ATP-induced Ca
2+ plateau (A). Error bars (<5%) have 
been omitted for better clarity. These data were reproduced at least in 
three different cell preparations.JCB • VOLUME 175 • NUMBER 3 • 2006  380
their activity in patch-clamp recordings using the whole-cell 
confi  guration or by following the [Ca
2+]i signal evoked via 
their activation by menthol. Fig. 4 A shows that human embry-
onic kidney 293 (HEK293) cells expressing TRPM8 channels 
respond to menthol stimulation with a large increase in an 
  outwardly rectifying current. TRPM8 channel activation by 
menthol is also refl  ected in the rapid and sustained [Ca
2+]i ele-
vation observed in transfected COS-7 (Fig. 4 B) or HEK293 
cells (not depicted). In cells also expressing the truncated 
FKBP12−5-ptase construct together with the PM-targeted FRB 
domain, addition of 100 nM rapa caused a prompt decrease in 
the menthol-induced current (Fig. 4 A). A rapid drop in [Ca
2+]i 
was also observed in COS-7 cells (Fig. 4 B) and HEK293 cells 
(not depicted). None of these changes were observed when rapa 
was added to cells expressing the PM-targeted FRB and the 
FKBP12 construct without the phosphatase (Fig. 4, A and B). 
These results clearly showed that TRPM8 channels require 
PtdIns(4,5)P2 for their activity and can report on rapid changes 
in the level of this lipid in intact cells. Interestingly, in spite of 
the apparently complete inhibition of the menthol-induced 
membrane conductance, [Ca
2+]i did not return to baseline after 
rapa addition. This remaining [Ca
2+]i elevation observed in both 
cell types could be explained by a stimulated store-operated 
Ca
2+ entry pathway if functional TRPM8 channels in the ER 
release ER Ca
2+ in response to menthol, as suggested by a re-
cent study (Thebault et al., 2005). This and other possibilities 
will require further analysis, as do questions on the role of the 
lipid in determining the menthol sensitivity and gating behavior 
of these channels.
PM PtdIns(4,5)P2 is needed 
for receptor internalization
We next examined how PtdIns(4,5)P2 depletion affects internal-
ization of the transferrin (Tf) and EGF receptors. It is generally 
believed that PtdIns(4,5)P2 regulates the recruitment of numer-
ous proteins to the PM that are required for receptor endocytosis 
(Wenk and De Camilli, 2004). To follow endocytosis, we used 
fl  uorescent analogues of Tf and EGF and incubated the cells 
with or without PtdIns(4,5)P2 depletion. We also determined the 
uptake of the fl  uorescent analogues in cells in which rapa in-
duced the translocation of an mRFP-FKBP12 construct without 
the phosphatase. As shown in Fig. 5, both Tf and EGF appeared 
in intracellular vesicular compartments in all cells regardless of 
their transfection with the constructs. This compartment corre-
sponds to early and recycling endosomes in the case of Tf and to 
the multivesicular body/late endosomal compartment in the case 
of EGF (van Dam et al., 2002; Minogue et al., 2006). Elimination 
of PtdIns(4,5)P2 with rapa addition completely prevented the 
uptake of either fl  uorescent cargo into the cells. These effects 
were not observed in rapa-treated cells that expressed the same 
constructs without the 5-ptase domain. A more quantitative as-
sessment of this process was obtained by FACS analysis in the 
case of Tf. Here, the mean green fl  uorescent intensity of the 
cells (a measure of internalized Tf) in the population of cells 
expressing the red (5-ptase) construct showed the changes ob-
served in the confocal pictures (Fig. 5 B). These data suggested 
that Tf receptors will not internalize when PtdIns(4,5)P2 is not 
available in the PM.
Collectively, these data clearly demonstrate that changes in 
membrane PtdIns(4,5)P2 levels by themselves without the gen-
eration of second messengers can have multiple consequences 
on a wide range of cellular processes. In a similar manner, modu-
lation of phosphoinositides in defi  ned membrane compartments 
can be achieved by recruiting other enzymes (phosphatases and 
kinases) to the PM or to other cellular membrane compartments 
to analyze the role of PtdIns(4,5)P2 or other inositol lipids in 
specifi  c cellular processes. Although this approach has con-
siderable potential, caution and the use of appropriate controls 
are essential to avoid possible artifacts. Numerous cellular pro-
cesses are based on FKBP12 interactions, and overexpression 
of an FKBP12 construct could alter their properties. Similarly, 
rapa is an inhibitor of mTOR that can exert several effects on 
its own. This problem is alleviated with the use of the rapalogue 
that does not bind to the endogenous protein. Lastly, the targeting 
of the FRB by itself can have its own effects on selected cel-
lular functions. However, if these possibilities are kept in mind 
Figure 4.  Electrophysiological recordings in HEK293 cells and [Ca
2+]i 
changes in single COS-7 cells expressing TRPM8 channels. Cells were also 
transfected with the membrane-targeted FRB-CFP plasmid and either the 
mRFP-FKBP−fused isolated 5-ptase domain or mRFP-FKBP only. (A) Current 
recording measured in the whole-cell conﬁ  guration, using the ramp proto-
col described in Materials and methods. The currents at +100 (top curves) 
and −100 mV (bottom curves) are shown. The averaged responses to 
rapa from 14 and 4 recordings for 5-ptase and FKBP-only expressing cells, 
respectively, measured at +100 mV are shown in the bottom histogram. 
(B) Averaged [Ca
2+]i responses from cells expressing the mRFP−FKBP−
5-ptase domain (left, red) or mRFP-FKBP only (left, black) domain (means ± 
SEM from 79 and 76 cells, respectively). Representative single-cell [Ca
2+]i 
responses from cells expressing the mRFP−FKBP−5-ptase domain are shown 
at the right (means ± SEM from 79 and 76 cells, respectively). Elimination 
of PtdIns(4,5)P2 rapidly inhibits the whole cell current and reduces the 
Ca
2+ signal stimulated by 500 μM menthol.INDUCIBLE CHANGES IN MEMBRANE PHOSPHOINOSITIDES • VARNAI ET AL. 381
this technique can permit further exploration of the complex 
regulatory features of phosphoinositides.
Materials and methods
Materials
AP21967 was obtained from Ariad Pharmaceuticals. Rapa and Tg were 
purchased from Calbiochem. Alexa 488−Tf and Alexa 488−EGF were 
obtained from Invitrogen. All other chemicals were purchased from Sigma-
Aldrich and were of highest analytical grade.
DNA constructs
The PLCδ1PH-GFP construct and its color variants have been previously 
  described (Várnai and Balla, 1998; van Der Wal et al., 2001). For PM tether-
ing, the N-terminal localization sequence (M  L  C  C  M  R  R  T  K  Q  V  E  K  N  D  D  D  Q  K  I  ) 
of the human GAP43 (residues 1–20) was fused to the N terminus of the 
FRB domain of human mTOR1 (residues 2019–2114 ampliﬁ   ed from a 
  human EST available from GenBank/EMBL/DDBJ under accession no.
5495577) through a short linker. To visualize the fusion protein, the con-
struct was tagged with CFP or mRFP (mRFP provided by R.Y. Tsien, University 
of California, San Diego, San Diego, CA). The T2098L mutant version of 
FRB was generated by exchanging the FRB portion from the plasmid ob-
tained from the Argent heterodimerization kit (Ariad Pharmaceuticals). 
Three constructs were designed that contained FKBP12 (ampliﬁ  ed from a 
human EST available from GenBank/EMBL/DDBJ under accession no.
3504715). All of them contained mRFP fused to the N terminus of FKBP12. 
The human type IV 5-ptase enzyme (available from GenBank/EMBL/DDBJ 
under accession no. NM_019892; provided by P.W. Majerus, Washington 
University, St. Louis, MO) was then fused to the C terminus of the FKBP12 
either as the full-length protein or only its 5-ptase domain (residues 
214–644). In both cases, the C641A mutation was introduced to destroy 
the C-terminal CAAX domain. A construct containing a stop codon at the 
end of the FKBP12 was also created (FKBP only).
Confocal analysis of single cells and [Ca
2+]i measurements
COS-7 cells were cultured on glass coverslips (3 × 10
5 cells/35-mm dish) 
and transfected with the various constructs (2 μg of total DNA/dish) using 
Lipofectamine 2000 for 24 h as described elsewhere (Varnai et al., 2005). 
For Ca
2+ measurements, cells were loaded with 3 μM fura-2/AM (45 min, 
room temperature). Ca
2+ measurements were performed at room tempera-
ture in a modiﬁ  ed Krebs-Ringer buffer containing 120 mM NaCl, 4.7 mM 
KCl, 1.2 mM CaCl2, 0.7 mM MgSO4, 10 mM glucose, and 10 mM 
Na-Hepes, pH 7.4. An inverted microscope (IX70; Olympus) equipped 
with an illuminator (Lambda-DG4; Sutter Instrument Co.) and a digital 
  camera (MicroMAX-1024BFT; Roper Scientiﬁ  c) and the appropriate ﬁ  lter sets 
were used for Ca
2+ analysis. Data acquisition and processing was per-
formed by the MetaFluor software (Molecular Devices). Confocal analysis 
was performed in the same solution at 35°C using a confocal microscope 
(LSM 510-META; Carl Zeiss MicroImaging, Inc.).
Patch-clamp recordings
Patch-clamp experiments were performed on HEK293 cells after 2 d of 
transfection with the respective DNA constructs. Recordings were made 
  using an ampliﬁ  er (Axopatch 200B; Axon Instruments, Inc.) in an  extracellu  lar 
solution containing 137 mM NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM 
Hepes, and 10 mM glucose, pH 7.4. The pipette solution contained 135 mM 
K gluconate, 5 mM KCl, 1 mM MgCl2, 5 mM EGTA, 10 mM Hepes, and 
2 mM ATP (Na)2, pH 7.2. To assess TRPM8 channel activity, voltage ramps 
were applied from −100 to +100 mV every second. The current values 
measured at the +100 and −100 mV potential are shown in the 
recordings. Menthol was used at a concentration of 500 μM and rapa 
at 100 nM.
Cell suspension FRET measurements
COS-7 cells were cultured in 10-cm dishes (3 × 10
6 cells) and transfected 
with equal amounts of PLCδ1PH-CFP and -YFP, as well as the mRFP version 
of the appropriate FRB and FKBP constructs (10 μg of total DNA/dish) 
  using Lipofectamine 2000 for 24 h. Cells were then trypsinized, centri-
fuged, and resuspended in the same modiﬁ  ed Krebs-Ringer solution used 
in the Ca
2+ experiments. Measurements were performed at 35°C using a 
Deltascan ﬂ  uorometer (PTI Technologies, Inc.) with excitation of 425 nm. 
To monitor the FRET signal, the ratio of the 525- and 475-nm emission 
was calculated.
Figure 5.  Internalization of Alexa 488−Tf or Alexa 488−EGF in COS-7 
cells transfected with the membrane-targeted FRB and the indicated FKBP 
constructs. Where indicated, ﬂ  uorescent ligand was added after 3-min pre-
treatment with 100 nM rapa. Confocal pictures were taken at 10 min after 
the addition of the ligand (Alexa 488−Tf in A and B and Alexa 488−EGF 
in C) and after removing and washing of the unbound protein. Note that 
the lack of internalization of Tf in cells expressing the 5-ptase domain was 
evident only after rapa addition (arrows). (B) FACS analysis of COS-7 cells 
expressing the membrane-targeted FRB-CFP plasmid and the indicated 
FKBP fusion protein after 5- or 10-min uptake of Alexa 488−Tf after treat-
ment with solvent or rapa. Cells showing mRFP expression in the red chan-
nel were selected and their mean green signal intensities were calculated. 
Means ± SEM of three experiments.JCB • VOLUME 175 • NUMBER 3 • 2006  382
FACS measurements
COS-7 cells were cultured in 10-cm dishes (3 × 10
6 cells) and trans-
fected with equal amounts of the appropriate FRB and FKBP constructs 
(10 μg of total DNA/dish) using Lipofectamine 2000 for 24 h. Cells 
were then trypsinized, centrifuged, and resuspended in the same solution 
that was used in the Ca
2+ experiments (10
6 cells/ml). After treating the 
cells with rapa (3 min) and then with ﬂ  uorescent transferrin (5 min) they 
were ﬁ  xed with 2% PFA. FACS measurements were performed using a 
FACScan instrument (Becton Dickinson). To monitor the internalization 
in the transfected cell populations, the red channel was set to analyze 
the  transfected cells and the mean green ﬂ   uorescence of these cells 
was calculated.
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science.1131163) described a similar approach to chemically manipulate 
PtdIns(4,5)P2 levels and KCNQ potassium channels.
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